NMPhA Mid-Winter Meeting “PHARMACY: THE CURE FOR ORDINARY”
PROGRAM AGENDA:
Hotel Albuquerque at Old Town
Albuquerque, New Mexico
Saturday, January 23, 2016
8:00am - 1:00pmExecutive Council Meeting
8:00amCouncil Breakfast
8:30amCouncil Meeting Begins
NoonCouncil Lunch
1:00pmCouncil Meeting Adjourns
1:00pm - 3:00pmConcurrent Programs
Law CE Program
2016 Board of Pharmacy Drug Law UpdateBen Kesner, RPh & Cheranne McCracken, PharmD
ACPE #: 0104-0000-16-001-L03-P / Contact Hours: 2.0 CEUs: 0.2 / Initial Release Date: 1/23/16
To familiarize health care professionals with new and/or changes to state and federal regulation or laws and to promote compliance with existing laws and regulations. At the completion of this knowledge-based presentation, the Pharmacist participant will be able to: 1) Identify and describe new drug laws and regulations;2) Identify and describe changes to existing drug regulation and laws; 3) Identify compliance problem areas in drug laws and regulations;
4) Define the Pharmacist role in compliance with the drug laws and regulations discussed and 5) Identify drug law trends.
ACPE #: 0104-0000-16-001-L03-T
At the completion of this knowledge-based presentation, the Pharmacy Technicianparticipant will be able to: 1) Identify and describe new drug laws and regulations; 2) Identify and describe changes to existing drug regulation and laws;
3) Identify compliance problem areas in drug laws and regulations; 4) Define the Pharmacy Technician role in compliance with the drug laws and regulations discussed and 5) Identify drug law trends.
Program Sponsored by: New Mexico Board of Pharmacy
1:00pm - 2:00pm
Current Topics Regarding the Use of Psychotropic Medication in Children and YouthM. Lynn Crismon, PharmD., FCCP, BCPP
ACPE #: 0104-0000-16-002-L01-P / Contact Hours: 1.0 CEU: 0.1 Initial Release Date: 1/23/16
At the completion of this knowledge-based presentation, the Pharmacist participant will be able to: 1) Discuss recent advances in pharmacotherapy for youth with mental disorders; 2) Delineate current controversies regarding the use of psychotropic medication in children and youth; 3) Describe how you would answer a question from a parent regarding potential suicidality associated with antidepressant use in adolescents and 4) Discuss methods to improve the utilization of psychotropic medication in children and adolescents.
ACPE #: 0104-0000-16-002-L01-T
At the completion of this knowledge-based presentation, the Pharmacy Technician participant will be able to: 1) Describe the controversial topics regarding the use of psychotropic mediations that parents and caregivers may ask pharmacy technicians; 2) Reflect on how you would address questions from parents and caregivers regarding the use of psychotropic medications in children and adolescents; 3) Discuss how pharmacy technicians can best assist pharmacists in addressing parent and caregiver concerns regarding the use of psychotropic medication in children and adolescents and 4) Consider the ways in which a pharmacy technician can collaborate with pharmacists and other healthcare personnel to improve he utilization of psychotropic medication in children and adolescents.
Program Sponsored by: The University of Texas at Austin College of Pharmacy
NMPhA Mid-Winter Meeting / Page 2 / Hotel Albuquerque at Old TownNMPhA Mid-Winter Meeting “PHARMACY: THE CURE FOR ORDINARY”
2:00pm - 3:00pm
Mandatory for Pharmacists prescribing Tobacco Cessation Products (One Live CE hour per year)
Increasing Smoking Cessation Rates with a Novel Pharmacotherapy: Intranasal Insulin Development at University of New Mexico Ajna Hamidovic, PharmD, MSACPE #: 0104-0000-16-011-L01-P / Contact Hours: 1.0 CEU: 0.1 Initial Release Date: 1/23/16
At the completion of this knowledge-based presentation, the Pharmacist participant will be able to: 1) Describe the process of genetic associations analyses that led to hypothesis that insulin is implicated in the pathophysiology of nicotine dependence; 2) Identify two mechanisms related to stress response that are targeted by intranasal insulin; 3) Discuss one shared neural mechanism between drug addiction and eating behavior; 4) Describe the effect of intranasal insulin on circulating free fatty acids and its possible implication in prevention of Type II diabetes and 5) Discuss whether intranasal insulin appears to be a safe treatment for smoking cessation.
ACPE #: 0104-0000-16-011-L01-T
At the completion of this knowledge-based presentation, the Pharmacy Technician participant will be able to: 1) Identify characteristics of Nicotine Dependence; 2) Describe three mechanisms of stress response that modulate nicotine dependence; 3) List the direction (i.e. increase, decrease, neutral) of intranasal insulin’s effect on circulating free fatty acids and 4) List safety outcomes collected during intranasal insulin.
Program Sponsored by: UNM College of Pharmacy
3:00pm - 3:15pmSnack Break
3:15pm - 4:15pmGeneral Session
What’s new in Type 2 Diabetes Management? New Drug Approvals and Treatment Recommendations Gretchen M. Ray, PharmD, PhC, BCACP, CDEACPE #: 0104-0000-16-003-L01-P / Contact Hours: 1.0 CEU: 0.1 / Initial Release Date: 1/23/16
At the completion of this knowledge-based presentation, the Pharmacist participant will be able to: 1) Describe the most recent drug approvals for type 2 diabetes including new insulins, DPP-4 inhibitors, GLP-1 agonists, and SGLT2 inhibitors; 2) Describe the 2015 management of hyperglycemia algorithm from the American Diabetes Association and 3) Describe updates from the 2016 American Diabetes Association standards of care in diabetes.
ACPE #: 0104-0000-16-003-L01-T
At the completion of this knowledge-based presentation, the Pharmacy Technician participant will be able to: 1) Describe the most recent drug approvals for type 2 diabetes including new insulins, DPP-4 inhibitors, GLP-1 agonists, and SGLT2 inhibitors; 2) Describe the 2015 management of hyperglycemia algorithm from the American Diabetes Association and 3) Describe updates from the 2016 American Diabetes Association standards of care in diabetes.
Program Sponsored by: UNM College of Pharmacy
4:15pm - 5:15pmGeneral Session
From Pubmed to Google: Evidence-Based Pharmacy Practice Using Online Information Resources Leslie A. McCament-Mann, PhD, RPhACPE #: 0104-0000-16-004-L04-P / Contact Hours: 1.0 CEU: 0.1 / Initial Release Date: 1/23/16
At the completion of this knowledge-based presentation, the Pharmacist participant will be able to: 1) Explain the 4-step evidence-based approach for resolving pharmacotherapy-related questions; 2) Differentiate the 3 categories of biomedical information sources and their best uses; 3) List commonly accessible, credible electronic drug information resources; 4) For a given therapeutic question, choose appropriate electronic resources, critically evaluate the evidence, and synthesize a clinically useful response and 5) Appropriately refer some drug information requests to the New Mexico Poison and Drug Information Center.
ACPE #: 0104-0000-16-004-L04-T
At the completion of this knowledge-based presentation, the Pharmacy Technician participant will be able to: 1) Explain the 4-step evidence-based approach for resolving pharmacotherapy-related questions; 2) Differentiate the 3 categories of biomedical information sources and their best uses; 3) List commonly accessible, credible electronic drug information resources; 4) For a given therapeutic question, choose appropriate electronic resources, critically evaluate the evidence, and synthesize a clinically useful response and 5) Appropriately refer some drug information requests to the New Mexico Poison and Drug Information Center. Program Sponsored by: New MexicoPoison & Drug Information Center
NMPhA Mid-Winter Meeting / Page 3 / Hotel Albuquerque at Old TownNMPhA Mid-Winter Meeting “PHARMACY: THE CURE FOR ORDINARY”
6:15pm - 9:00pmCOP Students/Recent Grad ‘Social Hour & Taco Bar’
Casa Esencia –
Light Hors d ‘Oeuvres & Refreshments served – Event co-sponsored by Cardinal Health
Sunday, January 24, 2016
7:00am – 8:00amFREE Cardiovascular Risk Screenings… (NO CE)
If interested, schedule your appointment with the NMPhA office @ 505-265-8729/800-464-8729. The screenings will include, a complete fasting lipid profile (includes good and bad cholesterol), blood glucose, blood pressure, body mass index, and a 10-year risk estimate for cardiovascular disease and stroke. The cholesterol and glucose tests require a small fingerstick sample of blood. For the most accurate results, participants should complete a 10 to 12 hour fast (nothing to eat or drink of caloric value) prior to the screening.
This program is put on by students from the UNM College of Pharmacy.
7:30amPick up name badges
Continental Breakfast
8:00am - 9:00amGeneral Session
2016 HIV Update Bernadette Jakeman, PharmD, PhC, BCPS, AAHIVPACPE #: 0104-0000-16-012-L02-P / Contact Hours: 1.0 CEU: 0.1 / Initial Release Date: 1/24/16
At the completion of this knowledge-based presentation, the Pharmacist participant will be able to: 1) Summarizekey updates to the DHHS treatment guidelines; 2) Identifyrecommended antiretroviral regimens for treatment-naive patients and 3) Describe common side effects and drug interactions associated with the recommended antiretroviral regimens.
ACPE #: 0104-0000-16-012-L02-T
At the completion of this knowledge-based presentation, the Pharmacy Technician participant will be able to: 1) Define HAART; 2) DefineCD4 cell count and HIV viral load and 3) Explain why combination therapy is required in the management of HIV.
Program Sponsored by: UNM College of Pharmacy
9:00am – 9:10amCoffee Break
9:10am - 10:10amConcurrent Sessions
Hypertension Treatment: Current Guidelines and Future DirectionsJames J. Nawarskas, PharmD, PhC, BCPSJoe R. Anderson, PharmD, PhC, BCPS
ACPE #: 0104-0000-16-005-L01-P / Contact Hours: 1.0 CEUs: 0.1 / Initial Release Date: 1/24/16
At the completion of this knowledge-based presentation, the Pharmacist participant will be able to: 1) Identify blood pressure goals for various populations from the latest guidelines; 2) State the drugs of choice for treating uncomplicated hypertension; 3) State the antihypertensive drugs of choice in patients with diabetes and kidney disease; 4) Describe the differences between previous and current hypertension guidelines and 5) State how upcoming hypertension treatment guidelines may change based on recent clinical trial results.
ACPE #: 0104-0000-16-005-L01-T
At the completion of this knowledge-based presentation, the Pharmacy Technician participant will be able to: 1) State how blood pressure guidelines are useful for helping to manage hypertension; 2) Identify the drugs of choice for treating uncomplicated hypertension; 3) Identify the antihypertensive drugs of choice in patients with diabetes and kidney disease and 4) State how upcoming hypertension treatment guidelines may change based on recent clinical trial results.
Program Sponsored by: UNM College of Pharmacy
NMPhA Mid-Winter Meeting / Page 4 / Hotel Albuquerque at Old TownNMPhA Mid-Winter Meeting “PHARMACY: THE CURE FOR ORDINARY”
9:10am - 10:10am
Drug Seeker or Genetic Genie Teri Rolan, PharmD, PhCACPE #: 0104-0000-16-006-L04–P / Contact Hours: 1.0 CEU: 0.1 / Initial Release Date: 1/24/16
At the completion of this knowledge-based presentation, the Pharmacist participant will be able to: 1) Define pharmacogenomics and pharmacogenetics; 2) Review DNA Basics; 3) Describe what a SNP is and how it relates to health outcomes; 4) Describe how DNA mutations like SNPs and copy-number variations impact proteins ; 5) Describe how genetic variations cause opioids to be metabolized differently and what the patient may experience when this occurs; 6) Give other examples of drug gene interactions and when pharmacogenomic testing may be appropriate; 7) List some limitations and ethical issues faced when using pharmacogenomic testing; 8) Distinguish what resources are available to help you better understand pharmacogenomic testing and it’s uses and 9) Direct patients that have done Direct to Consumer genetic testing.
ACPE #: 0104-0000-16-006-L04–T
At the completion of this knowledge-based presentation, the Pharmacy Technician participant will be able to: 1) Define pharmacogenomics and pharmacogenetics; 2) Review DNA Basics; 3) Describe what a SNP is and how it relates to health outcomes; 4) Recognize a potential patient that could benefit from pharmacogenomic testing and when to refer to the pharmacist and/or doctor and 5) Recognize some of medications where testing can be useful.
10:15am - 11:15amGeneral Session
Mandatory for Pharmacists w/ Vaccination Prescriptive Authority (One Live CE hour per year)
Immunizations: Pharmunize Part I - Vaccine Update and ReviewAmy Bachyrycz, PharmD
ACPE #: 0104-0000-16-007-L01-P / Contact Hours: 1.0 CEU: 0.1 / Initial Release Date: 1/24/16
At the completion of this knowledge-based presentation, the Pharmacist participant will be able to: 1) Outline IZ prescriptive authority protocol updates; 2) Review new ACIP recommendations and guidelines; 3) Define process for yellow fever vaccinations in NM; 4) Define use of travel vaccines/medications using patient vignettes and 5) Determine pharmacist impact on vaccination rates in NM.
ACPE #: 0104-0000-16-007-L01-T
At the completion of this knowledge-based presentation, the Pharmacy Technician participant will be able to: 1) Outline IZ prescriptive authority protocol updates; 2) Review new ACIP recommendations and guidelines; 3) Define significance of yellow fever vaccinations in NM and 4) Define NMSIIS and VFC as it relates to NM.
11:20am – 12:20pmGeneral Session: Pain Management/Patient Safety CPE
Mandatory for Pharmacists w/ Naloxone Prescriptive Authority (One Live CE hour per year)
Pain Management: News Flash: NM Pharmacist Saves Lives with NaloxoneDhara Shah Lari, PharmD Candidate & Amy Bachyrycz, PharmD& Jennifer Smith, PharmD
ACPE #: 0104-0000-16-008-L05-P / Contact Hours: 1.0 CEU: 0.1 Initial Release Date: 1/24/16
At the completion of this application-based presentation, the Pharmacist participant will be able to: 1) Explain preliminary data collected through the Naloxone Pharmacist Prescriptive Authority Program; 2) Evaluate specific trends in opioid overdose prevention in New Mexico pharmacies; 3) Demonstrate opioid overdose as a social problem; 4) Collaborate with others to identify areas of high opioid mortalities in NM; 5) Identify other healthcare professional’s role in decreasing opioid overdose and 6) Assisting in next steps to decrease opioid overdose deaths in NM.
ACPE #: 0104-0000-16-008-L05-T
At the completion of this application-based presentation, the Pharmacy Technician participant will be able to: 1) Explain the Naloxone Pharmacist Prescriptive Authority Program; 2) Evaluate opioid overdose prevention in New Mexico pharmacies; 3) Demonstrate opioid overdose as a social problem; 4) Collaborate with others to identify areas of high opioid mortalities in NM and 5) Assisting in next steps to decrease opioid overdose deaths in NM.
Program Sponsored by: UNM College of Pharmacy
NMPhA Mid-Winter Meeting / Page 5 / Hotel Albuquerque at Old TownNMPhA Mid-Winter Meeting “PHARMACY: THE CURE FOR ORDINARY”
12:30pm – 2:00pmLuncheon
Installation of Officers/Awards Presentation
Introduction of 2016 Officers & Councilors
Legislative Update – R. Dale Tinker
UNM COP Update – Dr. Lynda Welage
2:00pm – 3:00pmGeneral Session
The “No Fear” DEA Audit Shirley J. ScottACPE #: 0104-0000-16-009-L04-P / Contact Hours: 1.0 CEU: 0.1 Initial Release Date: 1/24/16
At the completion of this knowledge-based presentation, the Pharmacist participant will be able to: 1) Learn what a DEA audit consists of and how to prepare for one. CSA requirements will be reviewed in brief as well.
ACPE #: 0104-0000-16-009-L04-T
At the completion of this knowledge-based presentation, the Pharmacy Technician participant will be able to: 1) Learn what a DEA audit consists of and how to prepare for one. CSA requirements will be reviewed in brief as well.
Program Sponsored by: Drug Enforcement Administration
3:00pm - 3:30pmIce Cream/Coffee Break
3:30pm - 4:30pmGeneral Session
Pain, Trauma, and Health Krishna J. Chari, Psy.DACPE #: 0104-0000-16-010-L04-P / Contact Hours: 1.0 CEU: 0.1 Initial Release Date: 1/24/16
At the completion of this knowledge-based presentation, the Pharmacist participant will be able to: 1) Describe the intrinsic link between chronic pain conditions and emotional distress; 2) Review and be able to conceptualize psychological trauma and its impact on physical health conditions and its mutual maintenance of chronic disease; 3) Differentiate between different types of stressors (i.e. acute, traumatic, complex traumatic), and understand the differing manifestations of stress in psychological disorders and physical disease and 4) Identify the mind-body link between emotional stress and physical health.
ACPE #: 0104-0000-16-010-L04-T
At the completion of this knowledge-based presentation, the Pharmacy Technician participant will be able to: 1) Describe the intrinsic link between chronic pain conditions and emotional distress; 2) Review and be able to conceptualize psychological trauma and its impact on physical health conditions and its mutual maintenance of chronic disease; 3) Differentiate between different types of stressors (i.e. acute, traumatic, complex traumatic), and understand the differing manifestations of stress in psychological disorders and physical disease and 4) Identify the mind-body link between emotional stress and physical health.
Accreditation Council for Pharmacy Education Information
NMPhA Mid-Winter Meeting / Page 6 / Hotel Albuquerque at Old Town
NMPhA Mid-Winter Meeting “PHARMACY: THE CURE FOR ORDINARY”
Educational Grants & Program Sponsors
Cardinal Health
Drug Enforcement Administration
New Mexico Board of Pharmacy
New Mexico Pharmaceutical Care Foundation
New MexicoPoison & Drug Information Center
New Mexico Pharmacists Association
The University of Texas at Austin College of Pharmacy
UNM College of Pharmacy
Speaker Information
Joe R. Anderson, PharmD, PhC, BCPS
Associate Professor Pharmacy Practice and School of Medicine, University of New Mexico, Albuquerque, NM
Amy Bachyrycz, PharmD
Walgreen’s Patient Care Center Clinical Pharmacy Specialist; Clinical Assistant Professor, UNM College of Pharmacy, Albuquerque, NM
Krishna J. Chari, Psy.D
Clinical Psychologist & Assistant Medical Director, Pain Consultation and Treatment Center, UNMH, Albuquerque NM
M. Lynn Crismon, PharmD., FCCP, BCPP
Dean, James T. Doluisio Regents Chair and Behrens Centennial Professor, College of Pharmacy,
The University of Texas at Austin, Austin, TX
Ajna Hamidovic, PharmD, MS
Assistant Professor of Pharmacy and Psychiatry
University of New Mexico, Albuquerque, NM
Bernadette Jakeman, PharmD, PhC, BCPS, AAHIVP
Assistant Professor, Pharmacy Practice & Administrative Sciences, UNM College of Pharmacy, Albuquerque, NM
Ben Kesner, RPh
Executive Director, New Mexico State Board of Pharmacy, Albuquerque, NM
Leslie A. McCament-Mann, PhD, RPh
Assistant Professor, New MexicoPoison & Drug Information Center, UNM College of Pharmacy, Albuquerque, NM
Cheranne McCracken, PharmD, PhC, BCPS
Drug Inspector, New Mexico State Board of Pharmacy, Albuquerque, NM
James J. Nawarskas, PharmD, PhC, BCPS
Associate Professor, UNM College of Pharmacy, Albuquerque, NM
Gretchen M. Ray, PharmD, PhC, BCACP, CDE
Associate Professor of Pharmacy Practice; Director PGY2 Ambulatory Care Residencyt UNM College of Pharmacy, Albuquerque, NM
Teri Rolan, PharmD, PhC
Wylie Chemists Compounding Pharmacy, Santa Fe, NM
Shirley J. Scott
Diversion Investigator, Drug Enforcement Administration, Albuquerque, NM
Dhara Shah Lari
PharmD Candidate, UNM College of Pharmacy, Albuquerque, NM
Jennifer Smith, PharmD